IP Library Assignment 056285/0273
Patent Assignment
Reel/Frame 056285/0273

Assignment of Assignor's Interest

Recorded: 2021-05-19 Pages: 8
Assignors
VELICEPT THERAPEUTICS, INC.
Executed: 2021-04-21
Assignee
B3AR THERAPEUTICS, INC.
628 MIDDLEFIELD ROAD, PALO ALTO, CALIFORNIA, 94301
Covered Properties (17)
Solabegron Zwitterion and Uses Thereof
Application: 17/077,446 →
Publication: US 2021/0317073
Compositions of Micronized Solabegron and Methods of Use
Application: 63/168,817 →
Process for the Preparation of Arylethanolamine Derivatives Having an Anti-Obesity and Anti-Diabetic Properties
Patent: 6,548,523 →
Application: 10/148,841 →
Publication: US 2002/0198220
Phenethanolamine Derivatives, Compositions, and Their Use as Agonists at Atypical Beta-Adrenoreceptors
Patent: 7,034,053 →
Application: 10/470,860 →
Publication: US 2004/0106672
Process
Patent: 7,425,639 →
Application: 10/470,907 →
Publication: US 2004/0077868
Process of Preparing Arylethanoldiamines
Patent: 7,709,677 →
Application: 12/189,941 →
Publication: US 2008/0306278
Pharmaceutical Combinations of Beta-3 Adrenergic Receptor Agonists and Muscarinic Receptor Antagonists
Patent: 8,642,661 →
Application: 13/196,068 →
Publication: US 2012/0035118
Pharmaceutical Combination
Patent: 9,522,129 →
Application: 13/762,563 →
Publication: US 2013/0172277
Pharmaceutical Compositions and the Treatment of Overactive Bladder
Patent: 9,907,767 →
Application: 15/323,685 →
Publication: US 2017/0151199
Pharmaceutical Compositions and the Treatment of Overactive Bladder
Application: 15/868,582 →
Publication: US 2018/0147169
Pharmaceutical Compositions and the Treatment of Overactive Bladder
Application: 16/428,657 →
Publication: US 2019/0365683
Compositions and Methods of Using Modified Release Solabegron for Lower Urinary Tract Symptoms
Patent: 9,956,194 →
Application: 14/958,610 →
Publication: US 2016/0158176
Compositions and Methods of Using Modified Release Solabegron for Lower Urinary Tract Symptoms
Application: 15/951,968 →
Publication: US 2019/0083434
Solabegron Zwitterion and Uses Thereof
Application: 15/332,956 →
Publication: US 2017/0114005
Solabegron Zwitterion and Uses Thereof
Application: 16/018,945 →
Publication: US 2018/0370902
Solabegron Zwitterion and Uses Thereof
Application: 16/246,114 →
Publication: US 2019/0185414
Fixed Dose Pharmaceutical Compositions for Treating Overactive Bladder and Related Conditions
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Jul 8, 2002
From: GLAXO WELLCOME INC.
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 013070/0763 →
Assignment of Assignor's Interest Jul 8, 2002
From: LAWRENCE, RONNIE MAXWELL
To: GLAXO WELLCOME, INC.
Reel/Frame 013070/0724 →
Change of Name Jun 22, 2011
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 026503/0852 →
Assignment of Assignor's Interest Jul 25, 2011
From: GLAXOSMITHKLINE LLC
To: ALTHERX, INC.
Reel/Frame 026640/0943 →
Assignment of Assignor's Interest Oct 13, 2011
From: CALTABIANO, STEPHEN; OHLSTEIN, ELIOT; MCCALLUM, STEWART
To: ALTHERX, INC.
Reel/Frame 027055/0757 →
Assignment of Assignor's Interest Oct 3, 2013
From: CALTABIANO, STEPHEN; OHLSTEIN, ELIOT; MCCALLUM, STEWART
To: ALTHERX, INC.
Reel/Frame 031336/0689 →
Assignment of Assignor's Interest Nov 10, 2015
From: ALTHERX, INC.
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 037001/0974 →
Assignment of Assignor's Interest Sep 2, 2016
From: ALTHERX, INC.
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 039621/0163 →
Assignment of Assignor's Interest Jan 10, 2018
From: ALTHERX, INC.
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044587/0747 →
Assignment of Assignor's Interest Jan 10, 2018
From: STEVENS, RAYMOND E.
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044587/0802 →
Assignment of Assignor's Interest Jan 10, 2018
From: OHLSTEIN, ELIOT
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044587/0864 →
Assignment of Assignor's Interest Jan 10, 2018
From: WILKINS, H. JEFFREY
To: NST CONSULTING, LLC
Reel/Frame 044587/0925 →
Assignment of Assignor's Interest Jan 10, 2018
From: NST CONSULTING, LLC
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044588/0016 →
Assignment of Assignor's Interest Jan 10, 2018
From: ZHAO, DALIAN
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044589/0367 →
Assignment of Assignor's Interest Jan 10, 2018
From: STEVENS, RAYMOND E.
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044589/0463 →
Assignment of Assignor's Interest Jan 10, 2018
From: MOBELE, BINGIDIMI ITUTE
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044589/0418 →
Assignment of Assignor's Interest Jan 10, 2018
From: OHLSTEIN, ELIOT; MCCALLUM, STEWART; CALTABIANO, STEPHEN
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044585/0015 →
Assignment of Assignor's Interest Apr 16, 2018
From: OHLSTEIN, ELIOT; MCCALLUM, STEWART; CALTABIANO, STEPHEN
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 045553/0339 →
Assignment of Assignor's Interest Apr 20, 2018
From: NST CONSULTING, LLC
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 045600/0171 →
Assignment of Assignor's Interest Apr 20, 2018
From: WILKINS, H. JEFFREY
To: NST CONSULTING, LLC
Reel/Frame 045599/0918 →
Assignment of Assignor's Interest Apr 20, 2018
From: STEVENS, RAYMOND E.
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 045599/0754 →
Assignment of Assignor's Interest Apr 20, 2018
From: OHLSTEIN, ELIOT
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 045599/0642 →
Assignment of Assignor's Interest Jul 16, 2018
From: ZHAO, DALIAN; J-STAR RESEARCJ. INC.
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 046361/0263 →
Assignment of Assignor's Interest Jul 16, 2018
From: STEVENS, RAYMOND E.
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 046361/0375 →
Assignment of Assignor's Interest Jul 16, 2018
From: MOBELE, BINGIDIMI ITUTE; RONDAXE PHARMA, LLC
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 046361/0351 →